These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6540170)

  • 1. Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects.
    Riva R; Albani F; Ambrosetto G; Contin M; Cortelli P; Perucca E; Baruzzi A
    Epilepsia; 1984 Aug; 25(4):476-81. PubMed ID: 6540170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
    Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Gobbi G; Cortelli P; Procaccianti G; Baruzzi A
    Ther Drug Monit; 1984; 6(4):408-13. PubMed ID: 6542700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
    Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A
    Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects.
    Tomson T
    Arch Neurol; 1984 Aug; 41(8):830-4. PubMed ID: 6466158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects from the circadian fluctuations of carbamazepine plasma levels.
    Blennow G
    Acta Paediatr Scand; 1983 May; 72(3):397-401. PubMed ID: 6880726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects.
    Monaco F; Riccio A; Benna P; Covacich A; Durelli L; Fantini M; Furlan PM; Gilli M; Mutani R; Troni W; Gerna M; Morselli PL
    Neurology; 1976 Oct; 26(10):936-73. PubMed ID: 986584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine plasma concentration. Relationship to cognitive impairment.
    O'Dougherty M; Wright FS; Cox S; Walson P
    Arch Neurol; 1987 Aug; 44(8):863-7. PubMed ID: 3632397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diurnal fluctuations in plasma carbamazepine level in children with epilepsy].
    Losiowski Z; Prokopczyk J; Zimak J; Bielicka J
    Neurol Neurochir Pol; 1988; 22(3):195-200. PubMed ID: 3221956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects.
    Höppener RJ; Kuyer A; Meijer JW; Hulsman J
    Epilepsia; 1980 Aug; 21(4):341-50. PubMed ID: 7398602
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroocular side effects of carbamazepine and phenobarbital in epileptic patients as measured by saccadic eye movements analysis.
    Tedeschi G; Casucci G; Allocca S; Riva R; Di Costanzo A; Tata MR; Quattrone A; Baruzzi A; Bonavita V
    Epilepsia; 1989; 30(1):62-6. PubMed ID: 2912718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
    Paxton JW; Aman MG; Werry JS
    Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
    Macphee GJ; Butler E; Brodie MJ
    Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of downbeat nystagmus and oscillopsia associated with carbamazepine.
    Chrousos GA; Cowdry R; Schuelein M; Abdul-Rahim AS; Matsuo V; Currie JN
    Am J Ophthalmol; 1987 Feb; 103(2):221-4. PubMed ID: 3812624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy.
    Agbato OA; Elyas AA; Patsalos PN; Brett EM; Lascelles PT
    Arch Neurol; 1986 Nov; 43(11):1111-6. PubMed ID: 3778243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.
    Larkin JG; McKee PJ; Brodie MJ
    Br J Clin Pharmacol; 1992 Jan; 33(1):111-4. PubMed ID: 1540481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons of the month 2: A case of inappropriate drug-drug interaction in kidney transplant.
    Tan MH; Yee SY; Yahya R
    Clin Med (Lond); 2022 Mar; 22(2):169-171. PubMed ID: 35304379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.